Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
28.09.2023 00:29:00

XYL EQUITY ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Xylem Inc. Investors with Losses to Inquire About Securities Class Action Investigation - XYL

NEW YORK, Sept. 27, 2023 /PRNewswire/ -- 

Rosen Law Firm, P.A. Logo

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Xylem Inc. (NYSE: XYL) resulting from allegations that Xylem may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Xylem securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=19314 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

WHAT IS THIS ABOUT: On August 9, 2023, before the market opened, the investment firm Spruce Point Capital Management, LLC released a report entitled "A Leak in the Bull Case" (the "Report"), in which it outlined why it believes the price of Xylem stock will decline. Among other things, the Report alleged that certain financial figures which had been presented to investors regarding Xylem's 2023 acquisition of Evoqua were false. 

On this news, the price of Xylem stock declined by $2.82 per share, or 2.68% on August 9, 2023, on unusually high volume.  

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      lrosen@rosenlegal.com
      pkim@rosenlegal.com
      cases@rosenlegal.com
      www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/xyl-equity-alert-rosen-top-ranked-investor-counsel-encourages-xylem-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation--xyl-301940977.html

SOURCE THE ROSEN LAW FIRM, P. A.

Analysen zu Xylem Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Xylem Inc. 121,35 1,08% Xylem Inc.